Global Animal Health Partnering Terms and Agreements 2017 to 2026

Animal Health Partnering Terms and Agreements 2017-2026

Understand how companies partner across the animal health industry using intelligence from 294 real-world agreements.

Animal Health Partnering Terms and Agreements 2017-2026 provides comprehensive intelligence on 294 partnering deals involving animal health products, technologies and development programs.

Partnerships play an important role throughout the animal health industry, enabling companies to access innovation, combine research and development capabilities, secure rights to products and technologies, expand manufacturing capacity and extend commercial reach.

These relationships can take many forms, from early research and development collaborations through to licensing, manufacturing, supply, distribution and commercialization agreements.

The report brings this activity together in one resource, enabling users to understand who is partnering, which deal structures are being used, where activity is concentrated, what financial terms have been disclosed and how companies are working together across development and commercialization.

Rather than focusing on a single transaction type, the report provides a broad view of animal health partnering across veterinary medicines, vaccines, diagnostics and related animal health technologies.

It combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.

The report is designed for business development, licensing, corporate strategy, R&D, commercial strategy, competitive intelligence and legal teams involved in animal health partnering.

Understand the animal health partnering landscape

The report analyzes animal health dealmaking from 2017 to 2026, including:

• Trends in partnering activity by year
• Most active animal health dealmakers
• Partnering activity by deal type
• Therapy and disease area
• Technology type
• Stage of development
• Leading deals by disclosed value
• Financial terms where available
• How animal health partnering strategies are evolving
• This provides a market-wide view of where partnering activity is concentrated and how companies are using external relationships to develop and commercialize animal health innovation.
• Compare different animal health partnership models
• Animal health partnerships can be structured in many different ways according to the product, technology, development stage, market opportunity and capabilities of the parties.

The report enables users to investigate multiple approaches, including:

• Research and development collaborations
• Licensing agreements
• Development partnerships
• Manufacturing and supply arrangements
• Distribution agreements
• Commercialization partnerships
• Other multi-component transactions
• This makes it possible to compare alternative partnering routes rather than considering individual agreement types in isolation.
• Benchmark animal health deal financials

The report provides dedicated analysis of disclosed financial terms across animal health partnering transactions, including:

• Headline deal values
• Upfront payments
• Milestone payments
• Royalty rates
• Users can investigate the individual transactions behind these benchmarks to understand the circumstances surrounding the disclosed economics.
• This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
• Financial benchmarks are most useful when interpreted alongside the structure, development stage, rights and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
• Identify leading animal health dealmakers and prospective partners
• The report identifies the most active animal health dealmakers and provides company-level transaction histories that enable users to investigate their previous partnering activity.

This can help users identify:

• Companies actively seeking external opportunities
• Prospective licensing and collaboration partners
• Organizations repeatedly active in particular animal health areas
• Companies with demonstrated interest in specific technologies
• Dealmakers active at relevant stages of development
• Potential commercial, distribution or development partners
• Competitors pursuing similar external innovation strategies
• Previous transaction activity provides useful evidence of where individual companies have demonstrated an appetite for external partnering.
• Understand where animal health partnering activity is concentrated

The report analyzes animal health transactions by:

• Deal type
• Therapy or disease area
• Technology type
• Stage of development
• Company
• This enables users to identify areas attracting partnering activity and focus on the subset of transactions most relevant to a particular product, technology or strategic objective.
• Understand how animal health agreements are structured

Depending on the transaction and available disclosure, users can investigate areas including:

• Rights granted and retained
• Research and development responsibilities
• Licensing scope
• Exclusivity
• Geographic and territorial rights
• Intellectual property
• Development and regulatory obligations
• Manufacturing and supply
• Distribution and commercialization responsibilities
• Financial consideration
• Milestones and royalties
• Governance
• Term and termination provisions
• These real-world examples provide useful reference points when considering how a new animal health partnership might be structured.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying contract documents for selected animal health transactions.

These agreements can provide substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:

• Scope of rights
• Intellectual property
• Development obligations
• Exclusivity and territory
• Financial terms
• Milestone triggers
• Royalty provisions
• Manufacturing and supply
• Commercialization responsibilities
• Termination and continuing rights
• For teams preparing or negotiating an animal health transaction, access to real agreement language provides valuable insight into how comparable partnerships have been structured in practice.
• Comprehensive animal health deal directory
• The report includes a comprehensive directory of 294 animal health partnering deals, providing a focused resource for identifying relevant precedent transactions and companies.

Deals can be investigated by:

• Company
• Stage of development
• Deal type
• Therapy or disease area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify comparable animal health transactions, prospective partners and relevant agreement structures.
• Animal Health Companies
• Benchmark partnering activity, investigate potential partners and understand how peer companies are accessing external products and technologies.
• Pharmaceutical and Biotechnology Companies
• Understand partnering activity in animal health and identify organizations actively developing and commercializing veterinary products and technologies.
• Companies Seeking Animal Health Partners
• Identify organizations with demonstrated interest in relevant products, technologies, disease areas and stages of development.
• Corporate and R&D Strategy teams
• Track how companies are using external partnerships to access innovation and build animal health portfolios.
• Commercial and Market Strategy teams
• Investigate distribution, commercialization and other partnerships used to extend the reach of animal health products.
• Competitive and Market Intelligence teams
• Analyze activity by company, technology, disease area, stage and transaction type to understand evolving strategic priorities.
• Legal and Transaction teams
• Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
• Turn market-wide animal health intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying animal health deal intelligence to the customer's own products, technologies, portfolio or partnering objectives.
• Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, deal structures, development-stage analysis, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.